SCHEDULE: Tan Cheng Guan Discloses 8.79% Stake in China SXT
Beneficial Ownership Disclosure
Tan Cheng Guan has disclosed a beneficial ownership of 8.79% in China SXT Pharmaceuticals, Inc., holding over 10 million ordinary shares.
Summary
- Tan Cheng Guan, a Singaporean citizen, has filed a Schedule 13G disclosing beneficial ownership in China SXT Pharmaceuticals, Inc.
- The filing indicates ownership of 10,196,080 ordinary shares, representing 8.79% of the company's total voting power.
- The percentage is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025.
- The total voting power of the Issuer is 116,053,826 votes, comprising 116,027,226 Class A Ordinary Shares (one vote each) and 532 Class B Ordinary Shares (fifty votes each).
- Tan Cheng Guan holds 10,196,080 Class A Ordinary Shares.
- The shares were not acquired for the purpose of changing or influencing control of the issuer, nor in connection with any transaction having that purpose, other than activities solely related to a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's operational or financial performance.
Positives
- NA
Negatives
- NA
Risks
- The filing does not detail specific risks related to the company's operations or financial health, as it is a beneficial ownership disclosure.
Future Outlook
This filing is a disclosure of current beneficial ownership and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a standard regulatory disclosure of a significant ownership stake in a publicly traded pharmaceutical company. It does not provide insights into broader industry trends or competitive landscape.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: The disclosure of a new significant shareholder may influence market perception and trading activity for China SXT Pharmaceuticals, Inc. shares.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 07/29/2025 | Date of event which requires filing of this statement; also the date for outstanding share count. |
| 08/07/2025 | Date the Schedule 13G was signed by Tan Cheng Guan. |
Keywords
China SXT Pharmaceuticals, SXT, Pharmaceuticals, Beneficial Ownership, Schedule 13G, SEC Filing, Shareholder, Investment, Ordinary Shares, Voting Power
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.